Dublin, Ireland, 24th February 2021- ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered int...
Gain a 360-degree view of ICON Plc and make more informed decisions for your businessRegister your interest HeadquartersIreland AddressSouth County Business Park, Leopardstown, Dublin 18, 00000 Websitewww.iconplc.com Telephone353 1 2912000
The Directors present their report and audited Consolidated and Company Financial Statements of ICON plc (“the Company” or “ICON”), a public limited company incorporated in the Republic of Ireland, and its subsidiary undertakings (“the Subsidiaries”, with the Company and the Subsidiaries being...
ICON plc /s/ Nigel Clerkin Date: January 7, 2025 Nigel Clerkin Chief Financial Officer Exhibit 99.1 ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference Dublin, Ireland, January 7, 2025 – ...
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. It...
iconplc.com Are you an investor? Submit your portfolio details now to be considered in our investor rankings.Submit portfolio details Investments1 Partners & Customers10 Service Providers1 About ICON ICON (NASDAQ: ICLR) specializes in drug development for the pharmaceutical, biotechnology and medical ...
ICON PLC et overblik over aktiernes udvikling Tjek ICON PLC's tidligere økonomiske resultater, som omsætning eller nettoindkomst, plus den øverste oversigt over dens tidligere og nuværende markedsværdi. ICLR Aktiens udvikling Tidligere afslutning 1,050.765 Dagsområde 975.916 - ...
Record net business wins in the quarter of $1,080 million; a book to bill of 1.42. Full year net business wins of $3.8 billion; a net book to bill of 1.38.
Enterprise Irelandgrant awarded to ICON to further enhance artificial intelligence capabilities DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio ofartificial intelligence (...